Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutri Pharmaceuticals Research, Inc. (NPRI) is a biotechnology company specializing in advanced delivery systems for the nutraceutical and pharmaceutical industries. The company developed proprietary microencapsulation technologies, most notably Nutri-Sphere and Oz-Guard, which improve the stability and bioavailability of sensitive active ingredients. These technologies are particularly effective for Omega-3 fatty acids and fat-soluble vitamins, allowing for the creation of stable, powder-based formulations from oils. By providing superior taste-masking and protection against oxidation, NPRI's platforms enable the development of high-quality dietary supplements and functional foods. In December 2011, the company was acquired by Neptune Technologies & Bioressources, which is now known as Neptune Wellness Solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutri Pharmaceuticals Research.